CClinicalTrials.gg
CompletedNCT01885962iSHIFTupUpdated Apr 11, 2014

Development and Feasibility of an Internet Intervention for Adults With Spinal Cord Injury to Prevent Pressure Ulcers

An interventional study of iSHIFTup in Spinal Cord Injury and Pressure Ulcers, sponsored by University of Virginia. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-04-11.

Sponsored by University of Virginia · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
19
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The investigators propose to test the feasibility of iSHIFTup (Internet Skin Health Intervention For Targeted Ulcer Prevention) for adults with spinal cord injury (SCI) to prevent serious pressure ulcers (PrUs) and promote protective health behaviors. This protocol is Phase 2 of a three phase project. In Phase 1, the investigators developed iSHIFTup. In Phase 2, the investigators will test the intervention by partnering with Woodrow Wilson Rehabilitation Center (WWRC) to conduct a randomized controlled trial (RCT) of 18 participants. In Phase 3, the investigators will focus on optimizing the intervention based on our outcome findings and feedback, sustaining the program at WWRC, and seeking future funding for a larger RCT.

The investigators will conduct an RCT of up to 18 participants (9 participants in treatment as usual (TAU) group, 9 participants in TAU + iSHIFTup intervention group) (18 participants are needed to obtain statistically significant results).

The investigators will meet with potential participants in-person to complete the informed consent process and confirm eligibility. Participants in the TAU+iSHIFTup group will use the program during the study period. Participants randomized to TAU will have usual treatment during the study period and an opportunity to use the program following trial participation. The investigators will collect information from participants at two times during the study, at enrollment and post-intervention at 6-weeks (42 days). The investigators will also collect qualitative information from participants in the TAU+iSHIFTup group, during an optional focus-group setting, to learn users' experiences with the program. The investigators expect participants in the TAU+iSHIFTup group as compared to the TAU group, to display greater awareness of personal risk for pressure ulcers; increased preventive behaviors; and increased skin care self-efficacy and knowledge.

02

Conditions studied

  • Spinal Cord Injury
  • Pressure Ulcers

Keywords

  • pressure ulcer prevention
  • spinal cord injury
  • internet delivered pressure ulcer intervention
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 19 is below the median of 24 across 1,566 interventional studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

University of Virginia is the lead sponsor of 653 studies on the registry; 134 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 41 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • ≥ 18 years of age
  • history of Traumatic Spinal Cord Injury resulting in paraplegia or tetraplegia.
  • regular Internet access
  • physical ability to use computer
  • able to understand, read and speak English
  • have identified healthcare provider

Exclusion criteria

Exclusion Criteria:

  • SCI of non-traumatic etiology such as:

    • tumor,
    • ischemia,
    • developmental disorders,
    • neurodegenerative diseases,
    • demyelinative diseases,
    • transverse myelitis,
    • vascular malformations.
  • Severe pressure ulcer (stage 3 or stage 4).
  • Currently pregnant or plan to become pregnant during the study period.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
19 participants (actual)

Study arms

  • No intervention
    Treatment as Usual (TAU)

    Participants in this group engage in typical rehabilitation and perform usual skin care routine.

  • Experimental
    TAU + iSHIFTup

    Participants in this group engage in typical rehabilitation and use iSHIFTup, Internet Skin Health Intervention for Targeted Ulcer Prevention. Participants are instructed to perform program recommendations to engage in preventive skin care behaviors.

    Behavioral: iSHIFTup

Interventions

  • BehavioraliSHIFTup

    Internet-delivered program to support behaviors to prevent pressure ulcers and promote healthy skin in adults with spinal cord injury.

    Also known as: iSHIFTup, Internet Skin Health Intervention for Targeted Ulcer Prevention

06

What researchers measure

Primary outcomes

  1. Retrospective Diary Data

    This measure tracks skin care behaviors. It is completed by participants at enrollment and 42 days later. Change in baseline behaviors from baseline to 42 days is measured.

    Time frame: Baseline and 42 days

  2. Needs Assessment Checklist (Skin Management Subscale)

    Participants complete the NAC-SM after enrollment and again 42 days later. Change in NAC-SM scores from baseline to 42 days is measured.

    Time frame: Baseline and 42 Days

07

Study locations

1 site
  • Woodrow Wilson Rehabilitation Center
    Fishersville, Virginia 22939, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2014, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01885962
Lead sponsor
University of Virginia
Responsible party
Lee M Ritterband (Associate Professor, University of Virginia) — Principal investigator
First posted
Jun 25, 2013
Start date
May 2012
Primary completion
Jun 2013
Completion
Jun 2013
Last update
Apr 11, 2014

Study contacts

Lee M Ritterband, PhD
principal investigator · University of Virginia, Behavioral Health & Technology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2014. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion